The Type 2 Diabetes Care Gap Is a $413 Billion Problem
More than 17 million ER visits a year list diabetes as a contributing diagnosis. The capacity to catch these patients between visits does not exist under current workflows.
45%
of patients never reach their A1C goal
Poor adherence is the leading driver: 47% of patients discontinue T2D therapy entirely within a year, often between visits when no one is watching.
38M+
Americans live with Type 2 diabetes—90–95% of all diagnosed diabetes, climbing to 28.8% of adults 65+.
$412.9B
Spent treating diabetes in the US every year—2.6x the cost per patient of non-diabetic care.
A one-point drop in a patient’s medication adherence is associated with a 20.4% jump in ER visits and a 20.9% jump in hospitalizations. Quarterly office visits can’t catch that in time—continuous outreach can.
Infrastructure, Not Tools
Continua doesn’t replace your team—it multiplies their capacity to manage your highest-risk, highest-volume panel.
AI Pre-Processing
Voice and SMS AI agents check in between visits—logging glucose readings, reconciling metformin, GLP-1, and insulin regimens, and screening for cost-related non-adherence.
Human Validation
Your Care Coordinator reviews the AI summary, flags A1C or adherence red flags, and approves—in minutes.
Compliant Billing
Generates a billable, audit-proof encounter. You sign and bill APCM codes (G0556–G0558).
Backed by the Clinical Evidence
Continuous outreach between visits isn’t a nice-to-have—it’s clinically validated to move the outcomes that matter.
−0.48%
Average HbA1c drop from SMS follow-up alone—up to −1.15% combined with voice, in high-risk populations.
72%
Less documentation burden—clinicians save an average of 3.3 hours a week.
95%+
Sustained patient engagement, voice + SMS combined—reaching patients single-channel tools miss.
Proactive, algorithm-driven outreach programs report up to 45% fewer urgent care and ER visits by catching metabolic deterioration before it becomes an acute event.
Patient outcomes come first—but Riley’s outreach also frees your Care Coordinators from hours of manual follow-up (72% less documentation, ~3.3 hours saved a week) and generates a billable, audit-proof encounter you sign and bill under APCM codes G0556–G0558.
The Economic Engine
Built for the 2025 Medicare Physician Fee Schedule, where complexity-based reimbursement rewards the comorbidities that come standard with a Type 2 diabetes panel.
How Much Revenue Is Your Diabetes Panel Missing?
Drag the slider to match your APCM-eligible T2D patient count.
50
hrs saved / mo
$12,400
per month
$148,800
per year
Based on APCM (G0556–G0558) avg. reimbursement @ $62/patient/month. 20 min manual → 5 min with Continua.
Built for 2025 Billing
T2D rarely travels alone—it clusters with hypertension, CKD, and hyperlipidemia, so most panels clear Medicare’s complexity thresholds without extra work.
Rising-risk patients with one or fewer chronic conditions—like early-stage T2D—now billable for the first time under APCM.
Standard chronic care without the strict 20-minute timer. Ideal for stable T2D patients managed by AI.
Dual-eligible QMB patients with 2+ chronic conditions—hypertension, CKD, or hyperlipidemia alongside T2D—qualify automatically. Zero co-pay, maximum equity and revenue.
See It in Action
Patient View
Riley is ready to follow up on your chronic care plan.
Status: Ready
Provider Dashboard
LIVERiley Follows Up By Text, Too
A quick check-in that fits into a patient's day — no phone call required. Try replying below the way a patient would.
Riley works through a few real topics each check-in — how they're feeling, medication adherence, any ER visits — the same way a nurse would.
The whole conversation is automatically summarized into the patient's chart for provider review.
If a patient goes quiet, the check-in is summarized and flagged for the care team — nothing falls through the cracks.
Riley
Continua Health
Ready to Close Your Type 2 Diabetes Care Gap?
Join the waitlist to get early access, or tell us about your practice.